8 ms·
Well if there was a vaccine that reduced the risk of dying from drowning I think you’d definitely want to add it to the childhood vaccination schedule. Again, d
by strangeloops85 4y ago
Well if there was a vaccine that reduced the risk of dying from drowning I think you’d definitely want to add it to the childhood vaccination schedule. Again, death rate is not the only metric by which we decide what to vaccinate children for.
- briandon 4y agoWhat if the hypothetical risk-of-drowning vaccine were found to greatly heighten the young recipients', particularly young males', risk of myocarditis and pericarditis (among other potential adverse effects) and a significant percentage of those who developed myocarditis/pericarditis passed away within a few subsequent years? https://www.medrxiv.org/content/10.1101/2021.12.23.21268276v1 https://www.medrxiv.org/content/10.1101/2021.12.23.21268276v...
- n8henrie 4y agoBased on your link it looks like < 50 / million for a 3 vaccine series? Don't forget to consider the baseline risk of myocarditis in this cohort as well as the risk of myocarditis with COVID itself. I'm also not sure where you're finding numbers about the risk of serious morbidity or mortality with COVID-vaccine-associated myocarditis, please share if you know. My impression is that -- much like COVID -- while cases can be serious / fatal, most cases end up making a full recovery without further sequelae.
- briandon 4y agoThe myocarditis risk from covid, like most health risks from covid, is higher for the elderly and low for non-elderly people (see huge disparity in myocarditis risk found to result from a 2nd Moderna jab vs. covid infection for males under 40 in Patone et al. on MedRxiv). The mRNA and adenovirus-vector shots do not prevent infection or transmission and recent studies indicate vaccinated persons take longer to clear recent Omicron variants than those who have refused the vaccines [e.g. "Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection" (see "Figure 1. Viral Decay and Time to Negative Viral Culture."): https://www.nejm.org/doi/full/10.1056/NEJMc2202092 https://www.nejm.org/doi/full/10.1056/NEJMc2202092], so younger people aren't helping anyone else by subjecting themselves to the risks of the vaccines. Young, healthy people are being bullied and guilted and tricked into playing Russian roulette, repeatedly to nobody's benefit and at their own very real peril. Having apparently suffered no significant ill effects from a first or second or third shot doesn't even indicate that subsequent shots will be similarly well-tolerated. And myocarditis and pericarditis aren't the only severe or fatal adverse effects being observed. It's madness.
- n8henrie 4y ago> like most health risks is higher for the elderly FTFY > see huge disparity in myocarditis risk found to result from a 2nd Moderna jab vs. covid infection for males under 40 in Patone et al. on MedRxiv https://www.medrxiv.org/content/10.1101/2021.12.23.21268276v1 https://www.medrxiv.org/content/10.1101/2021.12.23.21268276v... """ This article is a preprint and has not been peer-reviewed ... Of the 42,200,614 persons included in the study population, 2,539 (0.006%) were hospitalised or died from myocarditis during the study period; 552 (0.001%) of these events occurred during 1-28 days following any dose of vaccine ... First, we confirm and extend our previous findings in more than 42 million persons that the risk of hospitalization or death from myocarditis following COVID-19 infection is higher than the risk associated with vaccination in the overall population. ... Despite more myocarditis events occurring in older persons, the risk following COVID-19 vaccination was largely restricted to younger males aged less than 40 years, where the risks of myocarditis following vaccination and infection were similar. However, the notable exception was that in younger males receiving a second dose of mRNA-1273 vaccine, the risk of myocarditis was higher following vaccination than infection, with an additional 101 events estimated following a second dose of mRNA-1273 vaccine compared to 7 events following a positive SARS-CoV-2 test ... Third, although we were able to include 2,136,189 children aged 13 to 17 years old in this analysis, the number of myocarditis events was too small (n=43 in all periods and n=15 in the 1-28 days post vaccination) in this population and precluded an evaluate of risk. ... In summary, the risk of hospital admission or death from myocarditis is greater following COVID-19 infection than following vaccination and remains modest following sequential doses of mRNA vaccine including a third booster dose of BNT162b in the overall population. However, the risk of myocarditis following vaccination is consistently higher in younger males, particularly following a second dose of RNA mRNA-1273 vaccine. """ I'm not sure that this strongly supports your apparent position. > recent studies indicate vaccinated persons take longer to clear recent Omicron variants than those who have refused the vaccines... so younger people aren't helping anyone else by subjecting themselves to the risks of the vaccines Except that absolute risk of getting infected in the first place is decreased in a vaccinated cohort. Which is pointed out by the same study you're referencing: "vaccination has been shown to reduce the incidence of infection and the severity of disease." So that kind of sounds like a way in which they might be helping both themselves and "anyone else." > And myocarditis and pericarditis aren't the only severe or fatal adverse effects being observed. What else? At what rates? Because I've certainly care for plenty of (by and large unvaccinated) people that have died from the disease, young (20s-30s, thankfully none younger have died in my care) as well as old. > It's madness. In that we agree.
- briandon 4y agoAs for mortality following clinical myocarditis, you can Google up the figures easily enough. Some authorities and experts have falsely claimed that vax-induced myocarditis was special and resolved without the long-term poor prognosis heretofore associated with myocarditis. Again, this is false. "Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis" https://www.jpeds.com/article/S0022-3476(22)00282-7/fulltext https://www.jpeds.com/article/S0022-3476(22)00282-7/fulltext
- n8henrie 4y ago> you can Google up the figures easily enough Is that right? I just keep hearing that there is some conspiracy trying to obscure the data, I figured it would be unavailable. https://pubmed.ncbi.nlm.nih.gov/34865500/ https://pubmed.ncbi.nlm.nih.gov/34865500/ We report on 139 adolescents and young adults with 140 episodes of suspected myocarditis (49 confirmed, 91 probable) at 26 centers. ... Twenty-six patients (18.7%) were in the intensive care unit, 2 were treated with inotropic/vasoactive support, and none required extracorporeal membrane oxygenation or died. Median hospital stay was 2 days (range, 0-10; IQR, 2-3). Of 97 patients who underwent cardiac MRI at a median 5 days (range, 0-88; IQR, 3-17) from symptom onset, 75 (77.3%) had abnormal findings: 74 (76.3%) had late gadolinium enhancement, 54 (55.7%) had myocardial edema, and 49 (50.5%) met Lake Louise criteria. Among 26 patients with left ventricular ejection fraction <55% on echocardiogram, all with follow-up had normalized function (n=25). https://jamanetwork.com/journals/jama/fullarticle/2788346 https://jamanetwork.com/journals/jama/fullarticle/2788346 Approximately 96% of persons (784/813) were hospitalized and 87% (577/661) of these had resolution of presenting symptoms by hospital discharge. The most common treatment was nonsteroidal anti-inflammatory drugs (589/676; 87%). https://pubmed.ncbi.nlm.nih.gov/34734240/ https://pubmed.ncbi.nlm.nih.gov/34734240/ All cases occurred within 2 weeks of a dose of the COVID-19 mRNA vaccine with the majority occurring within 3 days (range 1-13 days) following the second dose (6/7 patients, 86%). Overall, cases were mild, and all patients survived. COVID-19 Vaccination-Associated Myocarditis in Adolescents: https://pubmed.ncbi.nlm.nih.gov/34389692/ https://pubmed.ncbi.nlm.nih.gov/34389692/ None of the patients required inotropic, mechanical, or circulatory support. There were no deaths. Follow-up data obtained in 86% of patients at a mean of 35 days revealed resolution of symptoms, arrhythmias, and ventricular dysfunction. From the paper you linked to: """ Median hospital length of stay was 2 days (range 1-4 days) with no intensive care unit admission and no significant morbidity or mortality. All patients had resolution of chest pain and down-trending serum troponin level before discharge. Follow-up cardiac MRI LVEF (57.7 ± 2.8%) was significantly improved from initial (54.5 ± 5.5%, P < .05), and none of the patients had regional wall motion abnormalities. LVEF by echocardiogram was normal for all patients at the time of follow-up. """ Though to be fair -- because I think there are too many shills on both sides of this topic -- it also notes: """ Notably, in our cohort, although there was significant reduction in LGE at follow-up, abnormal strain persisted for the majority of patients at follow-up. """ So thank you for prompting me to delve a little more into the outcomes of the vaccine-associated myocarditis cases. I feel even more reassured than before -- the cases seem to be exceedingly rare, even in the highest risk demographic. For anyone outside that highest-risk demographic, the risk of COVID-related myocarditis is higher than vaccine-related. When this exceedingly rare complication occurs, the majority of cases result in a brief hospitalization during which they are treated with ibuprofen. I think it will be interesting to see how the risks of having COVID a second time compare with the risks of vaccination. I think it's fully possible that the immunity from prior infection could drastically reduce the risks of disease and shift the balance, but until this is better understood, it seems that the risks of vaccination seem to be extremely low -- even lower than the risks of COVID, even for the lowest risk demographics.